Article Correctness Is Author's Responsibility: Celiac disease might be cured by restoring immune tolerance to gliadin

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free. Immunologists developed and tested nanoparticles containing gliadin for the immunomodulatory treatment of celiac disease.